Chugai Pharmaceutical Co., Ltd.

TSE:4519 Rapporto sulle azioni

Cap. di mercato: JP¥11.9t

Chugai Pharmaceutical Crescita futura

Future criteri di controllo 1/6

Chugai Pharmaceutical prevede che gli utili e i ricavi cresceranno rispettivamente di 6% e 4.1% all'anno. Si prevede che l'EPS crescerà di 6% all'anno. Si prevede che il ritorno sul capitale proprio sarà di 17.3% in 3 anni.

Informazioni chiave

6.0%

Tasso di crescita degli utili

6.0%

Tasso di crescita dell'EPS

Pharmaceuticals crescita degli utili11.8%
Tasso di crescita dei ricavi4.1%
Rendimento futuro del capitale proprio17.3%
Copertura analitica

Good

Ultimo aggiornamento06 Nov 2024

Aggiornamenti recenti sulla crescita futura

Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Oct 29
Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Results: Chugai Pharmaceutical Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Jul 30
Results: Chugai Pharmaceutical Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 26
Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Recent updates

Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Oct 30
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Oct 29
Chugai Pharmaceutical Co., Ltd. Just Beat Revenue By 12%: Here's What Analysts Think Will Happen Next

Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Oct 15
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Should You Be Adding Chugai Pharmaceutical (TSE:4519) To Your Watchlist Today?

Oct 12
Should You Be Adding Chugai Pharmaceutical (TSE:4519) To Your Watchlist Today?

Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Sep 24
Chugai Pharmaceutical's (TSE:4519) Dividend Will Be ¥41.00

Results: Chugai Pharmaceutical Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Jul 30
Results: Chugai Pharmaceutical Co., Ltd. Exceeded Expectations And The Consensus Has Updated Its Estimates

Chugai Pharmaceutical (TSE:4519) Is Due To Pay A Dividend Of ¥41.00

Jul 27
Chugai Pharmaceutical (TSE:4519) Is Due To Pay A Dividend Of ¥41.00

Estimating The Intrinsic Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)

Jul 15
Estimating The Intrinsic Value Of Chugai Pharmaceutical Co., Ltd. (TSE:4519)

Chugai Pharmaceutical (TSE:4519) Is Increasing Its Dividend To ¥41.00

Jun 19
Chugai Pharmaceutical (TSE:4519) Is Increasing Its Dividend To ¥41.00

Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Business Is Trailing The Market But Its Shares Aren't

Jun 17
Chugai Pharmaceutical Co., Ltd.'s (TSE:4519) Business Is Trailing The Market But Its Shares Aren't

Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year

May 04
Chugai Pharmaceutical (TSE:4519) Is Paying Out A Larger Dividend Than Last Year

We Think That There Are Some Issues For Chugai Pharmaceutical (TSE:4519) Beyond Its Promising Earnings

May 01
We Think That There Are Some Issues For Chugai Pharmaceutical (TSE:4519) Beyond Its Promising Earnings

Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 26
Chugai Pharmaceutical Co., Ltd. (TSE:4519) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Mar 01
Chugai Pharmaceutical Co., Ltd. (TSE:4519) Investors Are Less Pessimistic Than Expected

Previsioni di crescita degli utili e dei ricavi

TSE:4519 - Stime future degli analisti e dati finanziari passati (JPY Millions )
DataRicaviGuadagniFlusso di cassa liberoLiquidità dell'operazioneAvg. Numero di analisti
12/31/20261,225,369424,365367,687422,83313
12/31/20251,157,047388,630347,751410,96715
12/31/20241,133,403375,129325,345390,05014
9/30/20241,142,350386,964349,434419,416N/A
6/30/20241,084,570355,041265,465327,068N/A
3/31/20241,036,076326,373323,991383,090N/A
12/31/20231,111,367325,472350,827409,925N/A
9/30/20231,276,051336,745205,825258,712N/A
6/30/20231,243,437326,969200,169252,605N/A
3/31/20231,211,632316,154252,376299,319N/A
12/31/20221,259,946374,429172,873244,112N/A
9/30/20221,143,716370,791298,989366,072N/A
6/30/20221,205,696389,011339,236422,551N/A
3/31/20221,191,496387,359227,919305,626N/A
12/31/2021999,759302,995206,760279,626N/A
9/30/2021887,919256,462180,866256,890N/A
6/30/2021809,055230,577194,361252,664N/A
3/31/2021776,339210,611165,601246,567N/A
12/31/2020786,946214,733143,646205,035N/A
9/30/2020753,853202,590127,482211,422N/A
6/30/2020734,019190,599108,080196,718N/A
3/31/2020711,320174,062116,245178,610N/A
12/31/2019686,184157,560145,464206,641N/A
9/30/2019662,198139,54383,362160,274N/A
6/30/2019614,949113,07043,280118,955N/A
3/31/2019586,64899,63123,827101,309N/A
12/31/2018579,78792,48841,403119,074N/A
9/30/2018572,99485,85791,950125,700N/A
6/30/2018566,54885,285N/A120,997N/A
3/31/2018556,15982,101N/A127,695N/A
12/31/2017534,19972,713N/A107,623N/A
9/30/2017517,90867,704N/A63,732N/A
6/30/2017497,02358,143N/A67,355N/A
3/31/2017497,35457,592N/A49,230N/A
12/31/2016491,78053,592N/A38,787N/A
9/30/2016492,58456,562N/A40,808N/A
6/30/2016506,19262,537N/A39,670N/A
3/31/2016501,64961,043N/A49,913N/A
12/31/2015498,83961,125N/A62,918N/A
9/30/2015495,45558,897N/A75,502N/A
6/30/2015479,26552,220N/A50,719N/A
3/31/2015454,14746,786N/A54,919N/A
12/31/2014461,10950,980N/A37,034N/A
9/30/2014450,54552,461N/A38,017N/A
6/30/2014444,65855,044N/A60,556N/A
3/31/2014457,28160,774N/A54,886N/A
12/31/2013423,65250,895N/A53,521N/A

Previsioni di crescita futura degli analisti

Guadagni vs tasso di risparmio: La crescita prevista degli utili di 4519 ( 6% all'anno) è superiore al tasso di risparmio ( 0.3% ).

Guadagni vs Mercato: Si prevede che gli utili di 4519 ( 6% all'anno) cresceranno più lentamente rispetto al mercato JP ( 8.8% all'anno).

Guadagni ad alta crescita: Si prevede che gli utili di 4519 cresceranno, ma non in modo significativo.

Ricavi vs Mercato: Si prevede che il fatturato di 4519 ( 4.1% all'anno) crescerà più lentamente rispetto al mercato JP ( 4.2% all'anno).

Ricavi ad alta crescita: Si prevede che il fatturato di 4519 ( 4.1% all'anno) crescerà più lentamente di 20% all'anno.

Previsioni di crescita dell'utile per azione

Rendimento futuro del capitale proprio

ROE futuro: Si prevede che il Return on Equity di 4519 sarà basso tra 3 anni ( 17.3 %).

Scoprire le aziende in crescita

7D

1Y

7D

1Y

7D

1Y